U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H21NO.BrH
Molecular Weight 324.256
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NORLEVORPHANOL HYDROBROMIDE

SMILES

Br.OC1=CC2=C(C[C@H]3NCC[C@@]24CCCC[C@@H]34)C=C1

InChI

InChIKey=LJAQABDSIONCIU-QALYCTJVSA-N
InChI=1S/C16H21NO.BrH/c18-12-5-4-11-9-15-13-3-1-2-6-16(13,7-8-17-15)14(11)10-12;/h4-5,10,13,15,17-18H,1-3,6-9H2;1H/t13-,15+,16+;/m0./s1

HIDE SMILES / InChI

Molecular Formula BrH
Molecular Weight 80.912
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C16H21NO
Molecular Weight 243.344
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

PubMed

PubMed

TitleDatePubMed
Neuropsychotoxic and neuroprotective potentials of dextromethorphan and its analogs.
2011
A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to in vitro CYP2D6 and CYP3A4 inhibition study.
2009-11
Inhibitory effect of glutamate release from rat cerebrocortical synaptosomes by dextromethorphan and its metabolite 3-hydroxymorphinan.
2009-07
Metabolism of dextrorphan by CYP2D6 in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism.
2009-02
Concise synthesis of dimemorfan (DF) starting from 3-hydroxymorphinan (3-HM).
2008-07
Neuropsychotoxicity of abused drugs: potential of dextromethorphan and novel neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and neuroprotective effects.
2008-01
Simultaneous analysis of dextromethorphan and its three metabolites in human plasma using an improved HPLC method with fluorometric detection.
2007-11-01
3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro.
2006-12
Selective effects of nitric oxide on the disposition of chlorzoxazone and dextromethorphan in isolated perfused rat livers.
2006-07
Effect of methamphetamine on the pharmacokinetics of dextromethorphan and midazolam in rats.
2005-10-28
Evaluation of dextromethorphan metabolism using hepatocytes from CYP2D6 poor and extensive metabolizers.
2005-06
Validation of a liquid chromatography-mass spectrometry method to assess the metabolism of dextromethorphan in rat everted gut sacs.
2005-05-05
3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.
2005-03
LC-MS/MS analysis of dextromethorphan metabolism in human saliva and urine to determine CYP2D6 phenotype and individual variability in N-demethylation and glucuronidation.
2004-12-25
Influence of phenylalanine 120 on cytochrome P450 2D6 catalytic selectivity and regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)-coumarin metabolism.
2004-12-01
Maintenance of liver functions in rat hepatocytes cultured as spheroids in a rotating wall vessel.
2003-08-02
Determination of dextromethorphan and its metabolites in rat serum by liquid-liquid extraction and liquid chromatography with fluorescence detection.
2003-05-25
New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice.
2003-03-07
A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine--application for drug interaction studies assessing potential CYP3A and CYP2D6 inhibition.
2002-08-22
The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein.
2002-07-26
Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?
2001-11
High-performance liquid chromatography assay for simultaneous determination of dextromethorphan and its main metabolites in urine and in microsomal preparations.
2001-04-15
Patents

Patents

Substance Class Chemical
Created
by admin
on Mon Mar 31 22:30:22 GMT 2025
Edited
by admin
on Mon Mar 31 22:30:22 GMT 2025
Record UNII
V44B57LQ23
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NORLEVORPHANOL HYDROBROMIDE
MI  
Common Name English
NORLEVORPHANOL HYDROBROMIDE [MI]
Preferred Name English
3-HYDROXYMORPHINAN HYDROBROMIDE
Systematic Name English
NORLEVORPHANOL HYDROBROMIDE, (-)-
Common Name English
MORPHINAN-3-OL, HYDROBROMIDE (1:1)
Systematic Name English
Code System Code Type Description
FDA UNII
V44B57LQ23
Created by admin on Mon Mar 31 22:30:22 GMT 2025 , Edited by admin on Mon Mar 31 22:30:22 GMT 2025
PRIMARY
PUBCHEM
5486108
Created by admin on Mon Mar 31 22:30:22 GMT 2025 , Edited by admin on Mon Mar 31 22:30:22 GMT 2025
PRIMARY
CAS
63732-85-4
Created by admin on Mon Mar 31 22:30:22 GMT 2025 , Edited by admin on Mon Mar 31 22:30:22 GMT 2025
PRIMARY
EPA CompTox
DTXSID00980237
Created by admin on Mon Mar 31 22:30:22 GMT 2025 , Edited by admin on Mon Mar 31 22:30:22 GMT 2025
PRIMARY
MERCK INDEX
m8066
Created by admin on Mon Mar 31 22:30:22 GMT 2025 , Edited by admin on Mon Mar 31 22:30:22 GMT 2025
PRIMARY Merck Index
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY